The Next Frontier of Precision Medicine: Parkinson's Disease
Penn Medicine launched first-of-its-kind Parkinson's disease initiative to advance research and treatment
Precision medicine allows physicians to provide the most tailored diagnostic tools and treatments for patients. By knowing the nature of a disease with molecular-level accuracy, doctors can treat that root cause. Penn Medicine uses precision medicine to treat a wide variety of disorders, ranging from preterm birth to cancer to cardiovascular disease. With the newly-launched Molecular Integration in Neurological Diagnosis (MIND) Initiative, Penn is bringing the power of precision medicine to Parkinson’s disease research.
IOA IN THE NEWS
09/20/18Dr. Patrick J. Brennan understands the difficulties that millions of Americans encounter as they helplessly watch Alzheimer's…
07/27/18Finding a cure for Alzheimer’s disease has proved elusive. The drugs currently on the market only manage the symptoms of…
07/06/18Proteinopathies, the misfolded proteins responsible for neuron deaths, have a claim to fame when it comes to rare neurodegenerative…
Join the nearly 200 Institute on Aging Fellows and Associate Fellows and experience robust collaborative opportunities in aging at Penn, for funding opportunity alerts, pilot research grant opportunities, and updates on IOA activities.
FEATURED VIDEOVideo Archive
MAKE A GIFT
Support aging-related research, education, and care at the IOA!
THE SCIENCE OF AGING NEWSLETTER
In this issue:
- Penn Medicine's 7th Annual 5K for the IOA & Memory Mile Walk
- Meet Lisa Walke, New Chief of Geriatrics at Penn Medicine
… and more!
Download the 2018 Fall Newsletter here
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.